Neurocrine Biosciences Inc. (NBIX)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

12780 EL CAMINO REAL SAN DIEGO, CA 92130

Neurocrine Biosciences Inc discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders. The company's lead clinical development program, indiplon, is a drug for the treatment of insomnia.

Data as of 2021-03-06 09:51:11 -0500
Market Cap8.758 Billion Shares Outstanding93.944 Million Avg 30-day Volume948.078 Thousand
P/E Ratio21.50348 Dividend Yield0.0 EPS4.16
Price/Sales9.84 Debt to Equity1.54 EBITDA336.1 Million
Price to Book Value9.13 Forward PE35.58 Enterprise Value9.805 Billion
Total Cash801 Million Current Debt186.5 Million Gross Profit1.036 Billion
BETA0.79318 52-week High/Low136.26 / 72.14 Next Earnings Date2021-02-04 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from NBIX instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 5 7 -28.57% 4 (0.24%) 4 (0.25%) 0.0%
Funds Holding: 387 404 -4.21% 104 (6.25%) 122 (7.6%) -14.75%
13F shares: 89.375 Million 88.922 Million 0.51% 18.233 Million 18.14 Million 0.51%
% Ownership 95.6607 95.1762 0.51% 19.5154 19.4154 0.52%
New Positions: 59 66 -10.61% 11 28 -60.71%
Increased Positions 140 187 -25.13% 38 51 -25.49%
Closed Positions 71 67 5.97% 29 20 45.0%
Reduced Positions 147 107 37.38% 46 34 35.29%
Total Calls 401.662 Thousand 400.112 Thousand 0.39% 84.425 Thousand 149.4 Thousand -43.49%
Total Puts 1.213 Million 1.366 Million -11.22% 357 Thousand 379.8 Thousand -6.0%
PUT/CALL Ratio 3.02 3.41 -11.44% 4.23 2.54 66.54%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding NBIX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NBIX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

422.5 Thousand total shares from 55 transactions

Exercise Derivative Conversion (M)

368.6 Thousand total shares from 14 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LLOYD-SMITH MALCOLM CHIEF REGULATORY OFFICER

  • Officer
32,510 2021-02-10 6

ABERNETHY MATT CHIEF FINANCIAL OFFICER

  • Officer
27,912 2021-02-08 7

ROBERTS EIRY CHIEF MEDICAL OFFICER

  • Officer
35,924 2021-02-08 6

GORMAN KEVIN CHARLES CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
1,792,416 2021-02-05 5

BOZIGIAN HAIG P. CHIEF DEVELOPMENT OFFICER

  • Officer
622,102 2021-02-05 5

GRIGORIADIS DIMITRI E. CHIEF RESEARCH OFFICER

  • Officer
335,076 2021-02-05 7

GANO KYLE CHIEF BUSINESS DEVELOPMENT OFF

  • Officer
509,582 2021-02-05 4

LIPPOLDT DARIN CHIEF LEGAL OFFICER

  • Officer
129,893 2021-02-05 7

BENEVICH ERIC CHIEF COMMERCIAL OFFICER

  • Officer
74,824 2021-02-05 7

COOKE JULIE CHIEF HUMAN RESOURCES OFFICER

  • Officer
38,777 2021-02-05 5

LYONS GARY A

  • Director
223,697 2021-01-25 2

SHERWIN STEPHEN A

  • Director
27,055 2020-12-03 3

RASTETTER WILLIAM H

  • Director
0 2020-05-19 1

POPS RICHARD F

  • Director
0 2020-05-19 1

MORROW GEORGE J

  • Director
0 2020-05-19 1

NORWALK LESLIE V

  • Director
0 2020-05-19 1

SHARP SHALINI

  • Director
0 2020-02-01 0

SANDROCK ALFRED

  • Director
0 2019-05-22 0

NEVINNY CORINNE H

  • Director
0 2018-05-24 0

OBRIEN CHRISTOPHER FLINT FORMER CHIEF MEDICAL OFFICER

  • Officer
55,946 2018-02-05 0

MOLLICA JOSEPH A

  • Director
0 2017-05-22 0

COUGHLIN TIMOTHY P CHIEF FINANCIAL OFFICER

  • Officer
137,961 2017-02-06 0

GROS DAVID-ALEXANDRE C PRESIDENT & COO

  • Officer
0 2017-02-06 0

MITCHELL W THOMAS

  • Director
1,000 2015-06-23 0

NEUROCRINE BIOSCIENCES INC

  • Director
16,030 2015-04-07 0

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BVF INVESTMENTS LLC

BVF INC/IL

LAMPERT MARK N

  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
No longer subject to file 2012-02-09 0

VALEUR JENSEN MARGARET E EVP AND GENERAL COUNSEL

  • Officer
0 2011-08-31 0

VALE WYLIE W

  • Director
0 2011-05-25 0

VENROCK HEALTHCARE CAPITAL PARTNERS LP

VHCP CO-INVESTMENT HOLDINGS, LLC

HOVE ANDERS D

ROBERTS BRYAN E

VHCP MANAGEMENT, LLC

  • 10% Owner
4,784,689 2009-12-22 0

ROBERTS BRYAN E

  • 10% Owner
4,784,689 2009-12-22 0

HOVE ANDERS D

  • 10% Owner
4,784,689 2009-12-22 0

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BVF INVESTMENTS LLC

BVF INC/IL

  • 10% Owner
  • INDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERINDIRECT BENEFICIAL OWNER
5,946,547 2009-01-22 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

LLOYD-SMITH MALCOLM - Officer CHIEF REGULATORY OFFICER

2021-02-12 20:27:14 -0500 2021-02-10 S 600 $119.95 d 32,510 direct yes

LLOYD-SMITH MALCOLM - Officer CHIEF REGULATORY OFFICER

2021-02-12 20:27:14 -0500 2021-02-10 M 1,100 $35.99 a 33,610 direct

LLOYD-SMITH MALCOLM - Officer CHIEF REGULATORY OFFICER

2021-02-12 20:27:14 -0500 2021-02-10 M 600 $35.99 a 33,110 direct

LLOYD-SMITH MALCOLM - Officer CHIEF REGULATORY OFFICER

2021-02-12 20:27:14 -0500 2021-02-10 M 1,700 $35.99 d 21,533 direct

LLOYD-SMITH MALCOLM - Officer CHIEF REGULATORY OFFICER

2021-02-12 20:27:14 -0500 2021-02-10 S 1,100 $119.96 d 32,510 direct yes

LIPPOLDT DARIN - Officer CHIEF LEGAL OFFICER

2021-02-09 21:16:10 -0500 2021-02-09 S 186 $117.55 d 34,361 direct yes

LIPPOLDT DARIN - Officer CHIEF LEGAL OFFICER

2021-02-09 21:16:10 -0500 2021-02-09 M 30,000 $35.99 a 64,361 direct

LIPPOLDT DARIN - Officer CHIEF LEGAL OFFICER

2021-02-09 21:16:10 -0500 2021-02-09 M 36,194 $35.99 d 0 direct

LIPPOLDT DARIN - Officer CHIEF LEGAL OFFICER

2021-02-09 21:16:10 -0500 2021-02-09 S 6,008 $116.21 d 34,361 direct yes

LIPPOLDT DARIN - Officer CHIEF LEGAL OFFICER

2021-02-09 21:16:10 -0500 2021-02-09 M 186 $35.99 a 34,547 direct

LIPPOLDT DARIN - Officer CHIEF LEGAL OFFICER

2021-02-09 21:16:10 -0500 2021-02-09 M 6,008 $35.99 a 40,369 direct

LIPPOLDT DARIN - Officer CHIEF LEGAL OFFICER

2021-02-09 21:16:10 -0500 2021-02-09 S 30,000 $116.16 d 34,361 direct yes

LLOYD-SMITH MALCOLM - Officer CHIEF REGULATORY OFFICER

2021-02-09 21:20:23 -0500 2021-02-08 S 1,015 $116.87 d 32,510 direct yes

GORMAN KEVIN CHARLES - Director - Officer CHIEF EXECUTIVE OFFICER

2021-02-09 21:17:21 -0500 2021-02-08 S 4,343 $116.74 d 450,051 direct yes

COOKE JULIE - Officer CHIEF HUMAN RESOURCES OFFICER

2021-02-09 21:24:47 -0500 2021-02-08 S 913 $116.72 d 13,737 direct yes

LIPPOLDT DARIN - Officer CHIEF LEGAL OFFICER

2021-02-09 21:16:10 -0500 2021-02-08 A 41,444 a 41,444 direct

ROBERTS EIRY - Officer CHIEF MEDICAL OFFICER

2021-02-09 21:21:38 -0500 2021-02-08 A 7,439 a 7,439 direct

ROBERTS EIRY - Officer CHIEF MEDICAL OFFICER

2021-02-09 21:21:38 -0500 2021-02-08 S 740 $116.67 d 17,231 direct yes

ABERNETHY MATT - Officer CHIEF FINANCIAL OFFICER

2021-02-09 21:30:30 -0500 2021-02-08 S 2,030 $116.81 d 14,869 direct yes

LIPPOLDT DARIN - Officer CHIEF LEGAL OFFICER

2021-02-09 21:16:10 -0500 2021-02-08 S 687 $116.69 d 31,914 direct yes

BENEVICH ERIC - Officer CHIEF COMMERCIAL OFFICER

2021-02-09 21:26:12 -0500 2021-02-08 A 44,632 a 44,632 direct

GRIGORIADIS DIMITRI E. - Officer CHIEF RESEARCH OFFICER

2021-02-09 21:18:48 -0500 2021-02-08 A 38,256 a 38,256 direct

GRIGORIADIS DIMITRI E. - Officer CHIEF RESEARCH OFFICER

2021-02-09 21:18:48 -0500 2021-02-08 S 687 $116.67 d 83,456 direct yes

BENEVICH ERIC - Officer CHIEF COMMERCIAL OFFICER

2021-02-09 21:26:12 -0500 2021-02-08 S 845 $116.89 d 18,018 direct yes

BOZIGIAN HAIG P. - Officer CHIEF DEVELOPMENT OFFICER

2021-02-09 21:27:51 -0500 2021-02-08 A 3,188 a 3,188 direct

GANO KYLE - Officer CHIEF BUSINESS DEVELOPMENT OFF

2021-02-09 21:42:22 -0500 2021-02-08 A 44,632 a 44,632 direct

GANO KYLE - Officer CHIEF BUSINESS DEVELOPMENT OFF

2021-02-09 21:42:22 -0500 2021-02-08 S 1,070 $116.89 d 102,406 direct yes

BOZIGIAN HAIG P. - Officer CHIEF DEVELOPMENT OFFICER

2021-02-09 21:27:51 -0500 2021-02-08 S 824 $116.85 d 154,934 direct yes

LLOYD-SMITH MALCOLM - Officer CHIEF REGULATORY OFFICER

2021-02-09 21:20:23 -0500 2021-02-08 A 5,314 a 5,314 direct

GORMAN KEVIN CHARLES - Director - Officer CHIEF EXECUTIVE OFFICER

2021-02-09 21:17:21 -0500 2021-02-08 A 103,609 a 103,609 direct

LLOYD-SMITH MALCOLM - Officer CHIEF REGULATORY OFFICER

2021-02-09 21:20:23 -0500 2021-02-08 S 1,490 $116.74 d 31,597 direct yes

GORMAN KEVIN CHARLES - Director - Officer CHIEF EXECUTIVE OFFICER

2021-02-09 21:17:21 -0500 2021-02-08 S 2,875 $116.79 d 446,144 direct yes

COOKE JULIE - Officer CHIEF HUMAN RESOURCES OFFICER

2021-02-09 21:24:47 -0500 2021-02-08 A 5,314 a 5,314 direct

COOKE JULIE - Officer CHIEF HUMAN RESOURCES OFFICER

2021-02-09 21:24:47 -0500 2021-02-08 S 425 $116.76 d 12,915 direct yes

ROBERTS EIRY - Officer CHIEF MEDICAL OFFICER

2021-02-09 21:21:38 -0500 2021-02-08 A 44,632 a 44,632 direct

ABERNETHY MATT - Officer CHIEF FINANCIAL OFFICER

2021-02-09 21:30:30 -0500 2021-02-08 A 7,439 a 7,439 direct

LIPPOLDT DARIN - Officer CHIEF LEGAL OFFICER

2021-02-09 21:16:10 -0500 2021-02-08 S 1,522 $116.72 d 34,361 direct yes

ABERNETHY MATT - Officer CHIEF FINANCIAL OFFICER

2021-02-09 21:30:30 -0500 2021-02-08 S 880 $116.85 d 13,043 direct yes

BENEVICH ERIC - Officer CHIEF COMMERCIAL OFFICER

2021-02-09 21:26:12 -0500 2021-02-08 S 2,030 $116.84 d 21,099 direct yes

GRIGORIADIS DIMITRI E. - Officer CHIEF RESEARCH OFFICER

2021-02-09 21:18:48 -0500 2021-02-08 S 1,218 $116.70 d 85,273 direct yes

BOZIGIAN HAIG P. - Officer CHIEF DEVELOPMENT OFFICER

2021-02-09 21:27:51 -0500 2021-02-08 S 1,623 $116.79 d 157,651 direct yes

GANO KYLE - Officer CHIEF BUSINESS DEVELOPMENT OFF

2021-02-09 21:42:22 -0500 2021-02-08 S 1,623 $116.83 d 104,768 direct yes

LLOYD-SMITH MALCOLM - Officer CHIEF REGULATORY OFFICER

2021-02-09 21:20:23 -0500 2021-02-08 A 31,880 a 31,880 direct

GORMAN KEVIN CHARLES - Director - Officer CHIEF EXECUTIVE OFFICER

2021-02-09 21:17:21 -0500 2021-02-08 S 3,248 $116.72 d 452,972 direct yes

LLOYD-SMITH MALCOLM - Officer CHIEF REGULATORY OFFICER

2021-02-09 21:20:23 -0500 2021-02-08 S 756 $116.89 d 30,437 direct yes

COOKE JULIE - Officer CHIEF HUMAN RESOURCES OFFICER

2021-02-09 21:24:47 -0500 2021-02-08 A 31,880 a 31,880 direct

LIPPOLDT DARIN - Officer CHIEF LEGAL OFFICER

2021-02-09 21:16:10 -0500 2021-02-08 A 6,908 a 6,908 direct

ROBERTS EIRY - Officer CHIEF MEDICAL OFFICER

2021-02-09 21:21:38 -0500 2021-02-08 S 1,623 $116.83 d 18,693 direct yes

ABERNETHY MATT - Officer CHIEF FINANCIAL OFFICER

2021-02-09 21:30:30 -0500 2021-02-08 A 44,632 a 44,632 direct

LIPPOLDT DARIN - Officer CHIEF LEGAL OFFICER

2021-02-09 21:16:10 -0500 2021-02-08 S 1,198 $116.74 d 32,991 direct yes

BENEVICH ERIC - Officer CHIEF COMMERCIAL OFFICER

2021-02-09 21:26:12 -0500 2021-02-08 A 7,439 a 7,439 direct

GRIGORIADIS DIMITRI E. - Officer CHIEF RESEARCH OFFICER

2021-02-09 21:18:48 -0500 2021-02-08 A 6,376 a 6,376 direct

GRIGORIADIS DIMITRI E. - Officer CHIEF RESEARCH OFFICER

2021-02-09 21:18:48 -0500 2021-02-08 S 803 $116.69 d 84,178 direct yes

BENEVICH ERIC - Officer CHIEF COMMERCIAL OFFICER

2021-02-09 21:26:12 -0500 2021-02-08 S 1,395 $116.76 d 19,273 direct yes

BOZIGIAN HAIG P. - Officer CHIEF DEVELOPMENT OFFICER

2021-02-09 21:27:51 -0500 2021-02-08 A 532 a 532 direct

GANO KYLE - Officer CHIEF BUSINESS DEVELOPMENT OFF

2021-02-09 21:42:22 -0500 2021-02-08 A 7,439 a 7,439 direct

GANO KYLE - Officer CHIEF BUSINESS DEVELOPMENT OFF

2021-02-09 21:42:22 -0500 2021-02-08 S 1,000 $116.83 d 103,306 direct yes

BOZIGIAN HAIG P. - Officer CHIEF DEVELOPMENT OFFICER

2021-02-09 21:27:51 -0500 2021-02-08 S 1,395 $116.78 d 156,189 direct yes

GORMAN KEVIN CHARLES - Director - Officer CHIEF EXECUTIVE OFFICER

2021-02-09 21:17:21 -0500 2021-02-08 A 17,269 a 17,269 direct

LLOYD-SMITH MALCOLM - Officer CHIEF REGULATORY OFFICER

2021-02-09 21:20:23 -0500 2021-02-05 S 865 $114.15 d 29,675 direct yes

LIPPOLDT DARIN - Officer CHIEF LEGAL OFFICER

2021-02-09 21:16:10 -0500 2021-02-05 S 605 $114.05 d 30,627 direct yes

GRIGORIADIS DIMITRI E. - Officer CHIEF RESEARCH OFFICER

2021-02-09 21:18:48 -0500 2021-02-05 S 605 $113.76 d 82,169 direct yes

BENEVICH ERIC - Officer CHIEF COMMERCIAL OFFICER

2021-02-09 21:26:12 -0500 2021-02-05 S 809 $114.03 d 16,434 direct yes

GANO KYLE - Officer CHIEF BUSINESS DEVELOPMENT OFF

2021-02-09 21:42:22 -0500 2021-02-05 S 1,974 $114.09 d 100,439 direct yes

BOZIGIAN HAIG P. - Officer CHIEF DEVELOPMENT OFFICER

2021-02-09 21:27:51 -0500 2021-02-05 S 704 $113.79 d 153,328 direct yes

GORMAN KEVIN CHARLES - Director - Officer CHIEF EXECUTIVE OFFICER

2021-02-09 21:17:21 -0500 2021-02-05 S 2,422 $114.16 d 443,249 direct yes

COOKE JULIE - Officer CHIEF HUMAN RESOURCES OFFICER

2021-02-09 21:24:47 -0500 2021-02-05 S 605 $113.86 d 12,125 direct yes

GANO KYLE - Officer CHIEF BUSINESS DEVELOPMENT OFF

2021-02-09 21:42:22 -0500 2021-02-05 S 703 $113.77 d 98,663 direct yes

BENEVICH ERIC - Officer CHIEF COMMERCIAL OFFICER

2021-01-27 20:58:27 -0500 2021-01-26 M 300 $41.78 d 56,223 direct

BENEVICH ERIC - Officer CHIEF COMMERCIAL OFFICER

2021-01-27 20:58:27 -0500 2021-01-26 S 300 $120.00 d 15,805 direct yes

LLOYD-SMITH MALCOLM - Officer CHIEF REGULATORY OFFICER

2021-01-27 21:30:34 -0500 2021-01-26 M 600 $35.99 a 29,602 direct

LYONS GARY A - Director

2021-01-27 21:53:04 -0500 2021-01-26 S 400 $120.00 d 223,697 direct yes

BENEVICH ERIC - Officer CHIEF COMMERCIAL OFFICER

2021-01-27 20:58:27 -0500 2021-01-26 M 300 $41.78 a 16,105 direct

LLOYD-SMITH MALCOLM - Officer CHIEF REGULATORY OFFICER

2021-01-27 21:30:34 -0500 2021-01-26 S 500 $119.96 d 29,002 direct yes

BENEVICH ERIC - Officer CHIEF COMMERCIAL OFFICER

2021-01-27 20:58:27 -0500 2021-01-26 S 100 $120.00 d 15,705 direct yes

LLOYD-SMITH MALCOLM - Officer CHIEF REGULATORY OFFICER

2021-01-27 21:30:34 -0500 2021-01-26 M 1,100 $35.99 d 23,233 direct

LLOYD-SMITH MALCOLM - Officer CHIEF REGULATORY OFFICER

2021-01-27 21:30:34 -0500 2021-01-26 S 600 $119.98 d 29,002 direct yes

LLOYD-SMITH MALCOLM - Officer CHIEF REGULATORY OFFICER

2021-01-27 21:30:34 -0500 2021-01-26 M 500 $35.99 a 29,502 direct

BENEVICH ERIC - Officer CHIEF COMMERCIAL OFFICER

2021-01-27 20:58:27 -0500 2021-01-25 S 3,477 $120.03 d 17,405 direct yes

LLOYD-SMITH MALCOLM - Officer CHIEF REGULATORY OFFICER

2021-01-27 21:30:34 -0500 2021-01-25 M 8,958 $32.99 d 0 direct

LLOYD-SMITH MALCOLM - Officer CHIEF REGULATORY OFFICER

2021-01-27 21:30:34 -0500 2021-01-25 S 8,958 $119.95 d 29,002 direct yes

LLOYD-SMITH MALCOLM - Officer CHIEF REGULATORY OFFICER

2021-01-27 21:30:34 -0500 2021-01-25 M 4,601 $35.99 a 33,603 direct

BENEVICH ERIC - Officer CHIEF COMMERCIAL OFFICER

2021-01-27 20:58:27 -0500 2021-01-25 M 3,477 $41.78 d 56,523 direct

BENEVICH ERIC - Officer CHIEF COMMERCIAL OFFICER

2021-01-27 20:58:27 -0500 2021-01-25 M 3,477 $41.78 a 20,882 direct

LLOYD-SMITH MALCOLM - Officer CHIEF REGULATORY OFFICER

2021-01-27 21:30:34 -0500 2021-01-25 M 8,612 $35.99 d 24,333 direct

LLOYD-SMITH MALCOLM - Officer CHIEF REGULATORY OFFICER

2021-01-27 21:30:34 -0500 2021-01-25 M 8,958 $32.99 a 37,960 direct

LLOYD-SMITH MALCOLM - Officer CHIEF REGULATORY OFFICER

2021-01-27 21:30:34 -0500 2021-01-25 S 4,011 $119.99 d 29,002 direct yes

LYONS GARY A - Director

2021-01-27 21:53:04 -0500 2021-01-25 S 1,600 $120.03 d 224,097 direct yes

BENEVICH ERIC - Officer CHIEF COMMERCIAL OFFICER

2021-01-27 20:58:27 -0500 2021-01-25 S 1,600 $120.03 d 15,805 direct yes

LLOYD-SMITH MALCOLM - Officer CHIEF REGULATORY OFFICER

2021-01-27 21:30:34 -0500 2021-01-25 S 4,601 $119.98 d 29,002 direct yes

LLOYD-SMITH MALCOLM - Officer CHIEF REGULATORY OFFICER

2021-01-27 21:30:34 -0500 2021-01-25 M 4,011 $35.99 a 33,013 direct

ROBERTS EIRY - Officer CHIEF MEDICAL OFFICER

2021-01-12 16:17:59 -0500 2021-01-08 S 2,632 $111.06 d 15,845 direct yes 1.0541 6.3338 1.2575 10.4022 8 -1.9695 13

GORMAN KEVIN CHARLES - Director - Officer CHIEF EXECUTIVE OFFICER

2021-01-12 16:16:10 -0500 2021-01-08 M 143,449 $8.66 d 0 direct

GORMAN KEVIN CHARLES - Director - Officer CHIEF EXECUTIVE OFFICER

2021-01-12 16:16:10 -0500 2021-01-08 S 143,449 $110.21 d 441,071 direct yes 1.0541 6.3338 1.2575 10.4022 8 -1.9695 13

GORMAN KEVIN CHARLES - Director - Officer CHIEF EXECUTIVE OFFICER

2021-01-12 16:16:10 -0500 2021-01-08 S 164,801 $110.22 d 441,071 direct yes 1.0541 6.3338 1.2575 10.4022 8 -1.9695 13

GORMAN KEVIN CHARLES - Director - Officer CHIEF EXECUTIVE OFFICER

2021-01-12 16:16:10 -0500 2021-01-08 M 143,449 $8.66 a 584,520 direct 1.0541 6.3338 1.2575 10.4022 8 -1.9695 13

GORMAN KEVIN CHARLES - Director - Officer CHIEF EXECUTIVE OFFICER

2021-01-12 16:16:10 -0500 2021-01-08 M 164,801 $8.65 d 0 direct

GORMAN KEVIN CHARLES - Director - Officer CHIEF EXECUTIVE OFFICER

2021-01-12 16:16:10 -0500 2021-01-08 M 164,801 $8.65 a 605,872 direct 1.0541 6.3338 1.2575 10.4022 8 -1.9695 13

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
NEUROCRINE BIOSCIENCES INC NBIX 2021-03-08 22:15:03 UTC -0.1804 0.2504 2400000
NEUROCRINE BIOSCIENCES INC NBIX 2021-03-08 21:45:03 UTC -0.1804 0.2504 2400000
NEUROCRINE BIOSCIENCES INC NBIX 2021-03-08 21:15:03 UTC -0.1804 0.2504 2400000
NEUROCRINE BIOSCIENCES INC NBIX 2021-03-08 20:45:03 UTC -0.1808 0.2508 2400000
NEUROCRINE BIOSCIENCES INC NBIX 2021-03-08 20:15:03 UTC -0.1808 0.2508 2400000
NEUROCRINE BIOSCIENCES INC NBIX 2021-03-08 19:45:02 UTC -0.1808 0.2508 2400000
NEUROCRINE BIOSCIENCES INC NBIX 2021-03-08 19:15:02 UTC -0.1808 0.2508 2400000
NEUROCRINE BIOSCIENCES INC NBIX 2021-03-08 18:45:02 UTC -0.1808 0.2508 2400000
NEUROCRINE BIOSCIENCES INC NBIX 2021-03-08 18:15:02 UTC -0.1808 0.2508 2400000
NEUROCRINE BIOSCIENCES INC NBIX 2021-03-08 17:45:03 UTC -0.1808 0.2508 2400000
NEUROCRINE BIOSCIENCES INC NBIX 2021-03-08 17:15:03 UTC -0.1808 0.2508 2400000
NEUROCRINE BIOSCIENCES INC NBIX 2021-03-08 16:45:02 UTC -0.1819 0.2519 2400000
NEUROCRINE BIOSCIENCES INC NBIX 2021-03-08 16:15:03 UTC -0.1819 0.2519 2400000
NEUROCRINE BIOSCIENCES INC NBIX 2021-03-08 15:45:02 UTC -0.1819 0.2519 2400000
NEUROCRINE BIOSCIENCES INC NBIX 2021-03-08 15:15:03 UTC -0.1819 0.2519 2400000
NEUROCRINE BIOSCIENCES INC NBIX 2021-03-08 14:45:03 UTC -0.18 0.25 2400000
NEUROCRINE BIOSCIENCES INC NBIX 2021-03-08 14:15:03 UTC -0.18 0.25 2400000
NEUROCRINE BIOSCIENCES INC NBIX 2021-03-08 13:45:03 UTC -0.18 0.25 2400000
NEUROCRINE BIOSCIENCES INC NBIX 2021-03-08 13:15:03 UTC -0.18 0.25 2400000
NEUROCRINE BIOSCIENCES INC NBIX 2021-03-08 12:45:03 UTC -0.18 0.25 2300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Calamos Investment Trust/IL- Calamos Market Neutral Income Fund NBIX -170371.0 shares, $-16810506.57 2020-10-31 N-PORT
AGF Investments Trust- AGFIQ U.S. Market Neutral Momentum Fund NBIX -244.0 shares, $-23387.4 2020-12-31 N-PORT
AQR Funds- AQR Large Cap Relaxed Constraint Equity Fund NBIX -250.0 shares, $-22527.5 2019-09-30 N-PORT
NORTHERN LIGHTS FUND TRUST II- Invenomic Fund NBIX -4393.0 shares, $-433457.31 2020-10-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund NBIX -4.0 shares, $-346.2 2020-03-31 N-PORT
AdvisorShares Trust- AdvisorShares Dorsey Wright Short ETF NBIX -3801.0 shares, $-364325.85 2020-12-31 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund NBIX -100.0 shares, $-9585.0 2020-12-31 N-PORT

Elevate your investments